Visual compatibility of esmolol hydrochloride and various injectable drugs during simulated Y-site injection.
Explore the source record for details and available documents.
SEARCH · Search PubMed
Search indexed PubMed citations on genomics, clinical trials, systematic reviews and public health. Explore titles, authors and supplied subject terms, then open the PubMed record.
Quote a phrase for an exact phrase match. Source license links do not imply unrestricted reuse.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Recently evidence has been obtained for the coexistence of adrenaline (A), neuropeptide Y (NPY) and cholecystokinin (CCK) in the same neurons located in the dorsal subnuclei of the nucleus tractus solitarius (nTS). Furthermore, receptor autoradiographical studies show a partial overlap between alpha 2, NPY and CCK receptors in this area. In the present study intracisternal (i.c.) co-administration of A/CCK-8 SO4 and NPY/CCK-8 SO4 was performed. Sulphated CCK-8 counteracted the hypotensive responses of NPY and A in the alpha-chloralose anaesthetized male rat. One possible explanation may be that the A/NPY/CCK neurons, which may be directly innervated by the baroreceptor afferents, release CCK peptides as endogenous antagonists to modulate the adrenergic/NPY-ergic transmission lines via a receptor-receptor interaction. An additional explanation is the possibility that the interaction between CCK, NPY and adrenaline takes place at the network level.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.
Explore the source record for details and available documents.